S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
66,000% upside on tiny biotech? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
66,000% upside on tiny biotech? (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
66,000% upside on tiny biotech? (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
66,000% upside on tiny biotech? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
66,000% upside on tiny biotech? (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
66,000% upside on tiny biotech? (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
66,000% upside on tiny biotech? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
66,000% upside on tiny biotech? (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
66,000% upside on tiny biotech? (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
66,000% upside on tiny biotech? (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
66,000% upside on tiny biotech? (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
66,000% upside on tiny biotech? (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
LON:GSK

GSK (GSK) Share Forecast, Price & News

GBX 1,492
-2.00 (-0.13%)
(As of 09/29/2023 ET)
Compare
Today's Range
1,481.40
1,501.80
50-Day Range
1,345.40
1,535.80
52-Week Range
1,286.20
1,609
Volume
6.47 million shs
Average Volume
7.03 million shs
Market Capitalization
£61.17 billion
P/E Ratio
1,174.80
Dividend Yield
3.75%
Price Target
GBX 1,573.64

GSK MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
5.5% Upside
GBX 1,573.64 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.56
Upright™ Environmental Score
News Sentiment
0.47mentions of GSK in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
£67.32 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.74 out of 5 stars


GSK stock logo

About GSK (LON:GSK) Stock

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

GSK Price History

GSK Stock News Headlines

GSK (LON:GSK) Stock Rating Reaffirmed by JPMorgan Chase & Co.
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Up 14%! Are GSK shares set to soar?
GSK plc (LON:GSK) Given Consensus Rating of "Hold" by Brokerages
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
GSK (LON:GSK) Given New GBX 1,585 Price Target at Morgan Stanley
Scynexis to recall GSK-partnered antifungal from market
GSK plc (LON:GSK) Insider Hal Barron Acquires 219 Shares of Stock
How Is The Market Feeling About GSK?
GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention
UPDATE 1-US FDA approves GSK's blood cancer therapy
US FDA approves GSK's anemia treatment
BRIEF-Gsk Says Momelotinib Filing Accepted In Japan
See More Headlines
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Company Calendar

Last Earnings
7/29/2020
Ex-Dividend for 7/13 Dividend
5/18/2023
Dividend Payable
7/13/2023
Ex-Dividend for 10/12 Dividend
8/17/2023
Today
10/01/2023
Dividend Payable
10/12/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers—General
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
69,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,573.64
High Stock Price Forecast
GBX 2,000
Low Stock Price Forecast
GBX 1,245
Forecasted Upside/Downside
+5.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
£5.37 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£29.33 billion
Cash Flow
GBX 183.17 per share
Book Value
GBX 313 per share

Miscellaneous

Outstanding Shares
4,100,000,000
Free Float
N/A
Market Cap
£61.17 billion
Optionable
Optionable
Beta
0.30
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Ms. Emma Natasha Walmsley (Age 53)
    CEO & Director
    Comp: $4.79M
  • Ms. Julie Belita Brown (Age 61)
    CFO & Exec. Director
  • Ms. Shobie Ramakrishnan
    Chief Digital & Technology Officer
  • Mr. Tony Wood
    Chief Scientific Officer
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Sr. VP & Group Gen. Counsel of Legal & Compliance
  • Ms. Sally Jackson
    Sr. VP of Global Communications & CEO Office
  • Mr. David Simon Redfern BSc (Hons) (Age 57)
    CA, Pres of Corp. Devel.
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. Philip C. Thomson
    Pres of Global Affairs













GSK Stock - Frequently Asked Questions

Should I buy or sell GSK stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GSK in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings
or view top-rated stocks.

What is GSK's stock price forecast for 2023?

8 brokers have issued twelve-month target prices for GSK's shares. Their GSK share price forecasts range from GBX 1,245 to GBX 2,000. On average, they anticipate the company's stock price to reach GBX 1,573.64 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for GSK
or view top-rated stocks among Wall Street analysts.

How have GSK shares performed in 2023?

GSK's stock was trading at GBX 1,437.60 at the start of the year. Since then, GSK shares have increased by 3.8% and is now trading at GBX 1,492.
View the best growth stocks for 2023 here
.

How were GSK's earnings last quarter?

GSK plc (LON:GSK) released its quarterly earnings data on Wednesday, July, 29th. The company reported $56.90 earnings per share (EPS) for the quarter. GSK had a net margin of 52.60% and a trailing twelve-month return on equity of 33.22%.

How often does GSK pay dividends? What is the dividend yield for GSK?

GSK announced a dividend on Wednesday, July 26th. Stockholders of record on Thursday, August 17th will be paid a dividend of GBX 14 per share on Thursday, October 12th. This represents a dividend yield of 1.01%. The ex-dividend date is Thursday, August 17th. The official announcement can be viewed at this link.
Read our dividend analysis for GSK
.

Is GSK a good dividend stock?

GSK (LON:GSK) pays an annual dividend of GBX 56 per share and currently has a dividend yield of 3.63%. The dividend payout ratio is 4,409.45%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GSK.

What other stocks do shareholders of GSK own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AstraZeneca (AZN), General Electric (GE), Royal Dutch Shell (RDSB), Vodafone Group Public (VOD), Intel (INTC), NVIDIA (NVDA), Johnson & Johnson (JNJ), AT&T (T), Barclays (BARC) and Gilead Sciences (GILD).

What is GSK's stock symbol?

GSK trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How do I buy shares of GSK?

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is GSK's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,492.

How much money does GSK make?

GSK (LON:GSK) has a market capitalization of £61.17 billion and generates £29.33 billion in revenue each year. The company earns £5.37 billion in net income (profit) each year or GBX 1.27 on an earnings per share basis.

How many employees does GSK have?

The company employs 69,400 workers across the globe.

How can I contact GSK?

GSK's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The official website for the company is www.gsk.com. The company can be reached via phone at +44-20-80475000.

This page (LON:GSK) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -